Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains
- PMID: 20598727
- DOI: 10.1016/j.virol.2010.06.016
Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains
Abstract
The varicella-zoster virus (VZV) Oka vaccine strain (vOka) differs from the parental strain (pOka) at several amino acid positions, but the mutations responsible for the attenuation of vOka have not been clearly defined. The ORF0 of vOka carries some of the mutations. Although we found that the ORF0 of both strains was incorporated into virus particles, the C-terminal region of vOka ORF0 was presented on the virion surface and was N-glycosylated, suggesting that the mutation in vOka ORF0 changes it into a novel envelope glycoprotein. In a mutant virus in which pOka ORF0 was replaced by vOka ORF0, the molecular weight of ORF0 was altered, but the plaque size was not. In addition, a pOka recombinant virus lacking the hydrophobic domain of ORF0 grew equally well as the wild-type virus, indicating that the mutation in ORF0 is not by itself sufficient for the attenuation of the vOka virus.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.Virology. 2005 Feb 5;332(1):337-46. doi: 10.1016/j.virol.2004.10.047. Virology. 2005. PMID: 15661165
-
The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.J Virol. 2012 Oct;86(19):10695-703. doi: 10.1128/JVI.01067-12. Epub 2012 Jul 25. J Virol. 2012. PMID: 22837206 Free PMC article.
-
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus.Vaccine. 2007 Jun 28;25(27):5006-12. doi: 10.1016/j.vaccine.2007.04.064. Epub 2007 May 7. Vaccine. 2007. PMID: 17540483
-
Molecular analysis of the Oka vaccine strain of varicella-zoster virus.J Infect Dis. 2008 Mar 1;197 Suppl 2:S45-8. doi: 10.1086/522122. J Infect Dis. 2008. PMID: 18419407 Review.
-
Vaccine Oka variants and sequence variability in vaccine-related skin lesions.J Infect Dis. 2008 Mar 1;197 Suppl 2:S54-7. doi: 10.1086/522140. J Infect Dis. 2008. PMID: 18419409 Review.
Cited by
-
Mutagenesis of the Varicella-Zoster Virus Genome Demonstrates That VLT and VLT-ORF63 Proteins Are Dispensable for Lytic Infection.Viruses. 2021 Nov 16;13(11):2289. doi: 10.3390/v13112289. Viruses. 2021. PMID: 34835095 Free PMC article.
-
Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax.Virol J. 2011 Dec 16;8:547. doi: 10.1186/1743-422X-8-547. Virol J. 2011. PMID: 22176950 Free PMC article.
-
Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.J Virol. 2012 Nov;86(22):12198-207. doi: 10.1128/JVI.01280-12. Epub 2012 Aug 29. J Virol. 2012. PMID: 22933294 Free PMC article.
-
Herpesviruses possess conserved proteins for interaction with Nedd4 family ubiquitin E3 ligases.Sci Rep. 2018 Mar 13;8(1):4447. doi: 10.1038/s41598-018-22682-2. Sci Rep. 2018. PMID: 29535361 Free PMC article.
-
The live attenuated varicella-zoster virus vaccine vOka: Molecular and cellular biology of its skin attenuation.Hum Vaccin Immunother. 2025 Dec;21(1):2482286. doi: 10.1080/21645515.2025.2482286. Epub 2025 Mar 28. Hum Vaccin Immunother. 2025. PMID: 40153527 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources